This protocol is judged by an institutional review board, an impartial group that testimonials any medical trials involving humans. If a research consists of a Routine I drug, when the board approves the protocol as ethical, the researchers must submit an application for an investigational new drug (IND) variety from the FDA.Weiser urged social we